Entrada Therapeutics Inc (TRDA) — Financial Flexibility Index
Entrada Therapeutics Inc (TRDA) has a Financial Flexibility Index of -0.39x as of September 2025. Free cash flow of $-28.14 Million (operating CF $-28.31 Million minus capex $171.00K) represents 0% of total liabilities ($72.18 Million). Check Entrada Therapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Entrada Therapeutics Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Entrada Therapeutics Inc across 6 annual periods. See TRDA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Entrada Therapeutics Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Entrada Therapeutics Inc. For the full company profile including market capitalisation, see TRDA stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.39x | $-38.40 Million | $-41.56 Million | $97.64 Million | ▼ -161.3% |
| 2023 | 0.64x | $145.42 Million | $139.80 Million | $226.83 Million | ▲ +127.9% |
| 2022 | -2.30x | $-90.90 Million | $-93.79 Million | $39.50 Million | ▲ +64.6% |
| 2021 | -6.50x | $-46.28 Million | $-50.86 Million | $7.12 Million | ▼ -2278.4% |
| 2020 | -0.27x | $-23.25 Million | $-25.57 Million | $85.02 Million | ▲ +9.2% |
| 2019 | -0.30x | $-10.17 Million | $-10.80 Million | $33.76 Million | — |